Although much attention has been devoted to resveratrol, a unique polyphenol produced by plants and credited as potentially being responsible for the 'French paradox'-the observation that French people have a relatively low incidence of coronary heart disease, even though their diet is high in saturated fats-the oligomers of resveratrol have been largely ignored despite their high biological activity. Challenges in achieving their isolation in sufficient quantity from natural sources, coupled with an inability to prepare them easily synthetically, are seen as the main obstacles. Here we report a programmable, controlled and potentially scalable synthesis of the resveratrol family via a three-stage design. The synthetic approach requires strategy-and reagent-guided chemical functionalizations to differentiate two distinct cores possessing multiple sites with the same or similar reactivity, ultimately leading to five higher-order natural products. This work demonstrates that challenging, positionally selective functionalizations of complex materials are possible where biosynthetic studies have indicated otherwise, it provides materials and tools with which to unlock the full biochemical potential of this family of natural products, and it affords an intellectual framework within which other oligomeric families could potentially be accessed.
Resveratrol is to oligostilbenes what isoprene is to terpenes. Whether through highly evolved enzymatic pathways or diversification opportunities through uncontrolled reactions or both, these starting points lead to hundreds of unique frameworks (such as 1-3 and 5-7, in Fig. 1 ) with wide-ranging biological properties relevant to the treatment of cancer, AIDS and bacterial infections, among other diseases [1] [2] [3] [4] . For laboratory synthesis, although strategies, tactics and logic exist to access most terpenes controllably and thereby facilitate full biochemical and pharmaceutical explorations 3 , the same cannot be said of resveratrol-derived oligostilbenes 5, 6 .
These unique materials are produced by plants throughout the world as phytoalexins, serving as a first line of chemical defence against stresses such as fungal infections. That role may derive from the fact that these molecules, including 8-20 (Fig. 2) , can be formed readily from resveratrol (4) through its self-merger two or more times through numerous distinct C-C and C-O bond constructions. Indeed, to put that bond-forming diversity into perspective, most other similarly produced oligomer families have just one or two specific combination modes 6 . Although the biogenesis of this family is still unknown, a number of studies 4, 7, 8 point to a reasonable hypothesis based on two main phases of construction, stages that could be viewed as similar to the cyclase and oxidase paradigm of terpene biosynthesis 2, 3 .
In the first, radical and cation-based reaction cascades convert resveratrol (4) into multiple dimeric frameworks, including 8-15. These cores may result either through direct dimerization of 4 or rearrangement reactions of a given dimer (especially e-viniferin, 8) into additional frameworks under appropriate conditions to create an initial base of architectural and stereochemical diversity 7, 8 . Whether enzymes are involved in these processes is unknown, though the participation of some chiral entity at some stage seems reasonable given that many of these materials are isolated in an optically active form.
From these staging areas, further oligomerization can occur in a second synthesis stage, with one seemingly prevalent mode being the addition of new resveratrol units to generate dihydrofuran rings. As indicated by the representative structures shown for compounds 16-20 (refs 9-13) derived from the pallidol (12) and ampelopsin F (14) cores, these new ring systems are added with inconsistent regio-and stereospecificity. Although we do not know the degree to which a given plant species can dictate the synthetic distribution of these variants (and whether enzymes are involved), from a global perspective the possibility of concurrently garnering such diversity is probably advantageous because it affords a broader range of architectures and potential biochemical properties. Indeed, initial screens have shown that activity is correlated with both size and stereochemistry. For example, although resveratrol (4) has broad-spectrum activity in mouse models (and is implicated in the 'French paradox' in humans) 14, 15 , the addition of increasing numbers of resveratrol units produces compounds with greater specificity and potency [16] [17] [18] . Similarly, although ampelopsin H (17) and nepalensinol B (20) have the same cores, their stereochemical differences lead to different mechanisms of anti-cancer activity 19, 20 .
Given this general mode and purpose of synthesis, these materials are ideal compound collections for biochemical screening if they could be obtained in quantity. Unfortunately, achieving their isolation from natural sources even in minute amounts is challenging and labour-intensive, as is modulating their multiple reactive groups in a laboratory flask. Indeed, biosynthetic explorations based on exposing resveratrol (4) or varied protected forms to a single chemical or oxidase usually lead to complex product mixtures because the chemist cannot differentiate, at will, between the dozens of reaction pathways available, which is necessary to prepare a single structure [21] [22] [23] [24] [25] [26] . In fact, of those materials that can be isolated and characterized from such studies, most (and sometimes all) are non-natural; those of natural origin make up only a small percentage of the total family. The same outcome occurs if higher-order materials are exposed to resveratrol (4) under similar conditions 27 . By contrast, wholly stepwise, nonbiomimetic sequences empowered by retrosynthetic analysis can produce single dimeric members with control, but do not possess the strategic power to deliver a family-level solution for all frameworks 5,6,28-31 . Here we establish an approach with the potential to lead to the synthesis of the entire resveratrol collection controllably, one member at a time.
Programmable synthesis design
We anticipated that the clearly diverse, complicated, and potentially chaotic bond constructions of nature's resveratrol oligomer synthesis could be regulated in a laboratory flask if three separate goals proved achievable. The first goal-the rational, systematic, and controlled synthesis of the various dimeric cores-was accomplished by using 21 (Fig. 2) as an alternate starting point. Indeed, we have already converted this material into structures 10, 12, 13 and 14, a reduced form of 8, analogues of 9, several natural product variants of 11, and several additional unique dimeric natural products in both published 32, 33 and In the laboratory, we anticipated that three distinct goals (steps) would be needed to forge these materials in a controlled fashion. The first was the use of a unique starting material (21) well removed from resveratrol itself to generate the dimeric cores as shown in a. We then required regioselective functionalizations that could differentiate the highlighted positions on a symmetric and non-symmetric core (goal 2, blue boxes) and a dihydrofuran formation protocol with divergent stereocontrol (goal 3). These final challenges are the subject of this work (green shading).
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unpublished work; some of these syntheses have proceeded on the gram scale. The second and third goals are the subject of this study, tasks for which we initially targeted compounds 16-19 to address the challenges anticipated in adding resveratrol units controllably to any core. This process required (1) a means of differentiating the highlighted positions within symmetric and non-symmetric frameworks 12 and 14, not only from all the other non-highlighted sites but also from each other 34, 35 , and (2) a robust sequence that could potentially advance a given positionally differentiated material into either trans-dihydrofuran diastereoisomer. Both the second and third goals are easily stated, but we expected them to be quite challenging, especially the second, because it requires differentiation that nature may not deploy (or can perform only with enzymes) and that biomimetic approaches have not achieved.
Differentiation of the pallidol core
We began our studies by attempting to functionalize selectively the symmetric, protected pallidol core (22 in Fig. 3 ) using electrophilic aromatic substitution with bromine as our preferred tool. To prepare the dihydrofurans relevant to the resveratrol class, this task required selective functionalization of atom H A over atom H B , with H A needing to be replaced selectively both once and twice. Although theoretical calculations-performed with the B3LYP functional in conjunction with the 6-31G(d) basis set-indicated that the atoms labelled H A and H B were the most likely to be replaced of all those on the framework, the electron density maps and electrostatic potentials were equivalent within error for H A and H B . From an inspection of various threedimensional models, such as the one shown in the inset to Fig. 3 , H B appeared to be more accessible owing to the proximal nature of the hydrogens on the aliphatic core relative to H A . Experimentally, however, H A proved to be the natural site of electrophilic aromatic substitution with a synthesis of dibromide 23 achieved in 99% yield using two equivalents of N-bromosuccinimide (NBS). Despite this selectivity, it proved difficult to obtain the corresponding monobromide even at a yield of 50%, because the resultant material (not shown) readily underwent additional halogenation (generating 23) even when substoichiometric amounts of electrophilic bromine were used.
We thus needed an alternative strategy to desymmetrize compound 22, given that the goal appeared to be outside the power of reagent control. A compound obtained previously (25, formed from 24 through three consecutive regiospecific brominations and a Friedel-Crafts cyclization) 32 solved the problem because it is non-symmetric by virtue of its aliphatic bromine atom. Consequently, through initial removal of its aryl bromides followed by a site-selective rebromination controlled by the aliphatic bromide, we formed compound 26 in 
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79% yield as an effective surrogate of the originally targeted monobrominated congener of 22.
With this critical stage of selective functionalizations complete, we turned next to dihydrofuran formation. Although many methods exist to forge such rings from aryl bromides 36 , our efforts revealed that these approaches do not proceed on the highly electron-rich and sterically encumbered frameworks of the resveratrol class. Nevertheless, we were able to identify a reliable and novel solution to these challenges. These operations began (Fig. 3A) through the initial incorporation of additional 3,5-dimethoxyphenyl ring systems and a protecting group exchange to produce diaryl ketones (see Supplementary Information for structures); the exchange in phenol protecting groups was made at this stage to ensure that mild deprotection conditions could be deployed in the presence of sensitive and highly polar late-stage intermediates.
These steps were then followed by a Corey-Chaykovski epoxidation 37 and Lewis-acid-induced rearrangement (ZnI 2 or BF 3 NOEt 2 ) 38 to generate aldehydes 27-29 from 26 and 23, respectively. Although these operations collectively seem conventional, they were designed to both respond to, and take advantage of, the uniqueness of the resveratrol system while also ensuring effective diastereocontrol. Indeed, because of the electron-wealth of the neighbouring aromatic rings, the ketone precursors to 27-29 could not be engaged by arylcontaining organometallic, Wittig or diazo-forming reagents; they could, however, react with a sulphonium-ylide, and once converted into aldehydes, the adjoining electron-wealth proved invaluable in that it probably prevented 27-29 from epimerizing readily, as often occurs with such materials. For example, in the case of 29 only exposure to strong base (potassium hexamethyldisilazane, KHMDS) in tetrahydrofuran (THF) altered that stereochemistry, with this moderately yielding reaction indicating the inherent reprotonation bias of this system. Thus, with the ability to set these initial stereocentres, the stereodetermining portion of the sequence was complete, given that the remaining operations (Grignard addition and a one-pot deprotection/cyclization sequence through the specific intermediates shown in Fig. 3B for 16) 39 produced the desired trans-disposed dihydrofuran rings of carasiphenol C (16) , ampelopsin H (17) and the non-natural analogue 30. Crude 1 H nuclear magnetic resonance (NMR) spectra revealed that these materials were generated with .10:1 preference over any other compounds, with the very minor, unassigned products potentially being cis-dihydrofurans on the basis of a comparison to published NMR coupling constant values. We attribute the overall high level of trans-selectivity to a tendency to minimize strain, as shown in the precyclization intermediate in Fig. 3B , although we cannot rule out the possibility of equilibration of any cis-disposed products into the probably thermodynamically stable trans-materials under the acidic conditions used 40 .
Finally, we note that while we have not explicitly attempted a largescale synthesis of any of these final natural products (most reactions were performed with fewer than 100 mg of material for the sake of convenience, though the dimeric cores are available in gram quantities), we did advance enough material to obtain a 55 mg isolate from the final deprotection/cyclization sequence containing carasiphenol C (16) with at least 90% purity (based on 1 H and 13 C NMR analysis). To put that amount of synthetic material into context, only 10 mg of 16 was obtained from 70 kg of dried plant material in the original isolation effort 9 .
Differentiation of the ampelopsin F core
To assess whether these two final stages of synthesis had family-level applicability, we decided next to target natural products 18, 19 and 38 (Fig. 4) RESEARCH ARTICLE 31) . We expected that synthesis of these compounds would present an even greater challenge in positional selectivity because it necessitates the site-selective replacement of positions H A and H B (in either order) among four highly electron-rich positions. Physical models and theoretical calculations (using B3LYP/6-31G(d), as described above) revealed no obvious differences between these sites, indicating that all four hydrogens within 31 were equally likely to be replaced.
Experimentation soon revealed, however, that position H A could readily be functionalized with a variety of bromine sources (including under acidic conditions), producing 32 at a usually high yield (95% with slightly less than 1 equivalent of NBS); use of two equivalents of these reagents smoothly provided dibromide 33 (in 99% yield using NBS). Given the consistency of this outcome with reagents of varying size and reactivity, this functionalization pattern (H A then H B ) probably reflects substrate control. Thus, accessing 34 (H B before H A ) required reagent control, a result we felt was potentially achievable given that the use of a collidine/Br 2 complex afforded 34 along with roughly equal amounts of 32 in an uncontrolled electrophilic aromatic substitution reaction.
After much experimentation, we found that a bromonium source we had recently developed 41 -Et 2 SBrNSbCl 5 Br (bromodiethylsulphide bromopentachloroantimonate, BDSB)-was uniquely able to afford 34 cleanly in CH 2 Cl 2 ; the yield for this process was 78% (85% based on recovered starting material) when we performed the reaction on the .0.5 g scale. Only a small amount of 33 was formed from this process, with no 32 discernible by 1 H NMR analysis of the crude reaction mixture. To our knowledge, this reaction constitutes the most complex, positionally selective reagent-based bromination described thus far, complementing other catalyst-controlled processes 42 . We are currently investigating the basis for this selectivity, an important issue given that BDSB could potentially provide other uniquely functionalized aromatic building blocks.
Pleasingly, application of the same dihydrofuran formation sequence with these bromides led to diastereocontrolled syntheses of ampelopsin G (18), carasiphenol B (19) , and vaticanol C (38); the last of these targets (vaticanol C) is an exciting lead for cancer treatment and prophylaxis 17 . We found that high control in aldehyde stereochemistry was always obtained at position H A (as for 35), but was consistently a 1:1 mixture at position H B , as highlighted in 36 and 37, suggesting different inherent biases of the system. Strategically, however, it is important to note that we were also able to advance successfully the undesired aldehyde epimer from the ampelopsin G sequence into the diastereomeric dihydrofuran, synthesizing what is, at present, a non-natural analogue (see Supplementary Information). Thus, though we have not outlined a specific solution to forging these epimeric aldehydes controllably (given that natural products were the specific goal of this study), we believe the robustness of the terminating sequence provides a family-level solution for the clean preparation of any trans-dihydrofuran, dependent only on initial control of aldehyde stereochemistry. As such, the potential exists to access resveratrol-based diversity and biochemical reactivity in compounds not yet isolated from nature.
Conclusions and discussions
This work demonstrates, for the first time, that the controlled synthesis of higher-order resveratrol oligomers (and potentially the entire class) can be achieved. Salient features of the design are its reliance on a unique starting point coupled with challenging functionalizations on diverse and complex cores. Indeed, only through the introduction of a novel reagent (BDSB) was appropriate positional control achieved on one framework, while a strategic solution was required on the other framework. As such, these complex and positionally selective approaches indicate that the same and/or similar functionalities can be differentiated even on highly complex frameworks, countering the notion (based on previous biosynthetic explorations) that such processes could not be achieved. Moreover, the developed sequences provide opportunities to optimize biological activity and alter physicochemical properties by making analogues otherwise inaccessible from resveratrol alone.
To put the developed approach for the resveratrol class into strategic context, it reflects a hybrid of retrosynthetic analysis 43 and divergent/ diversity-oriented synthesis 44, 45 , a combination that could be argued to be obvious in terms of the bond connections desired, but is not obvious in terms of the tools needed to execute those reactions (particularly positionally selective transforms). Whether or not this overall strategy can be extended to the synthesis of other oligomer families remains to be established. What is certain is that the evaluation of that question will offer many opportunities for reagent and reaction discovery, particularly as more complex brominative functionalizations are examined using natural products, compounds pertinent to materials research, and building blocks needed for pharmaceuticals.
METHODS SUMMARY
All reactions were carried out under an argon atmosphere with dry solvents under anhydrous conditions; dry THF, toluene, benzene, diethyl ether, and CH 2 Cl 2 were obtained by passing commercially available pre-dried, oxygen-free formulations through activated alumina columns. Yields refer to chromatographically and spectroscopically ( 1 H and 13 C NMR) homogeneous materials, unless otherwise stated. Reagents were purchased at the highest commercial quality and used without further purification, unless otherwise stated. Reactions were magnetically stirred and monitored by thin-layer chromatography. For full experimental details, including procedures for all reactions and characterization of all new compounds ( 1 H NMR, 13 C NMR, mass spectrometry, infrared, R f value), see the Supplementary Information.
